A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response Read more
WATER IV Prostate Cancer: Aquablation versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer Read more
A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02) Read more
A Prospective Observational Protocol to Evaluate Clinical and Functional Outcomes After Focal Therapy in Patients with Prostate Cancer Read more
Integrating Cell-Free DNA Molecular Profiles with Clinical Metadata to Inform Early-Stage Colorectal and Breast Cancer Outcomes Read more
A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants with Advanced Solid Tumors Read more
A Phase 2 Study Evaluating the Efficacy of Anti-CD38 antibody in Combination with KRAS vaccine and Anti-PD-1 Antibody in Subjects with Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer Read more
A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Treatment of Physicians Choice in participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Read more
